Sometimes the most useful answer science offers is that a dramatic intervention is not needed. In a 530-patient international trial reported in the New England Journal of Medicine, researchers at the University of Calgary found that pulling clots out of medium-sized brain arteries did not leave stroke patients better off than standard medical care. The result draws a boundary around a procedure that has transformed treatment for larger blockages, reminding clinicians that the brain's network of vessels is not uniform and that care must fit the particular place where the blood has stopped flowi
ESCAPE-MeVO Trial Finds Clot Retrieval Does Not Improve Outcomes for Medium-Vessel Stroke
Ischemic stroke causes death and long-term disability, and the trial tested whether a procedure could improve these outcomes for patients with medium-vessel blockages.
Pulling a clot did not leave patients better off than standard care.
Sometimes the most useful answer science offers is that a dramatic intervention is not needed. In a 530-patient international trial reported in the New England Journal of Medicine, researchers at the University of Calgary found that pulling clots out of medium-sized brain arteries did not leave stroke patients better off than standard medical care. The result draws a boundary around a procedure that has transformed treatment for larger blockages, reminding clinicians that the brain's network of vessels is not uniform and that care must fit the particular place where the blood has stopped flowing.
A trial of 530 stroke patients across 58 sites in five countries has returned a clear answer: removing a clot from a medium-sized brain artery did not improve outcomes compared with standard medical care. The results, published in the New England Journal of Medicine and presented at the International Stroke Conference in Los Angeles, came from the University of Calgary's Hotchkiss Brain Institute and the Calgary Stroke Program at Foothills Medical Centre.
The study grew from the earlier ESCAPE Trial, which showed that endovascular thrombectomy could dramatically help patients with blockages in large vessels. The new question was whether smaller vessels would respond the same way. Patients were randomly assigned to usual care or usual care plus thrombectomy, and were assessed at 90 days using measures of disability and daily functioning. Neither measure favoured the procedure.
For clinicians, especially at smaller and rural centres where the procedure may not be available, the finding offers reassurance and guidance. Usual care, often including clot-busting drugs, performs as well here, and the patients are not losing a benefit by not receiving the procedure. The researchers will follow participants to one year to see whether any late advantage appears.
A trial that enrolled 530 stroke patients across 58 sites in five countries has delivered a clear negative result: pulling a clot out of a medium-sized brain artery did not leave patients better off than standard medical care. The findings were published in the New England Journal of Medicine and presented at the International Stroke Conference in Los Angeles.
The work comes from researchers at the University of Calgary's Hotchkiss Brain Institute, working with the Calgary Stroke Program at Foothills Medical Centre. The same group earlier ran the ESCAPE Trial, which showed that endovascular thrombectomy, or EVT, a procedure that retrieves a clot, can dramatically improve outcomes after an acute ischemic stroke caused by a blockage in a large vessel. Ischemic strokes are the most common form of stroke.
ESCAPE-MeVO was built on that result. The question was whether patients whose blockages sit in smaller, medium-sized vessels could benefit in the same way. Dr. Mayank Goyal, an interventional neuroradiologist and clinical professor at the Cumming School of Medicine who served as co-principal investigator, framed the stakes simply: brain cells die quickly once blood flow stops, and the brain is fed by a network of arteries of varying size. Doctors need to know which approach suits which situation.
The design was a randomized comparison. One group of patients received usual care. The other received EVT in addition to usual care. Everyone was assessed 90 days after the stroke, using two measures: the modified Rankin Score, which gauges the level of disability a person lives with after a stroke, and the Barthel Index, which measures the ability to carry out daily tasks.
On both counts, the answer was the same. Goyal said patients with medium-vessel blockages who had endovascular treatment did not do any better than those who received the standard of care.
Dr. Michael Hill, a neurologist, professor at the Cumming School of Medicine and the other co-principal investigator, said the findings will help doctors decide on the best treatment for each patient. Usual medical care, often including thrombolytic, or clot-busting, drugs, is best for medium-vessel blockages, he said, and knowing that helps with resourcing and with making sure each patient gets the right care for their circumstances.
Hill added that the results matter particularly for doctors treating stroke patients at smaller centres and in rural locations, where EVT may not be available. For those clinicians, the trial indicates that the absence of the procedure is not costing this group of patients a benefit.
Goyal described the broader purpose of the work as improving treatments and reducing death and disability from stroke, noting that the study clarifies when EVT works and when it does not.
The story is not entirely closed. Researchers will continue following the patients out to one year to see whether any late benefit emerges with a longer period of evaluation.
Citazioni salienti
Patients with medium-vessel blockages who had endovascular treatment did not do any better than those who had the standard of care.— Dr. Mayank Goyal, co-principal investigator
Knowing usual medical care is best for medium-vessel blockages helps with resourcing and ensuring each patient gets the right care.— Dr. Michael Hill, co-principal investigator (paraphrased)
Vuoi la storia completa?
Leggi l'originale su News-Medical.net ↗
Health & Medicine